Listed Funds Trust Roundhill Magnificent Seven ETF

MAGS

Market cap $3.44B

Most investors who own the Magnificent Seven already own them, scattered across index funds, QQQ, and individual positions.

The Mag Seven ETF is lagging behind small-caps and equal-weight tech. It would be a mistake, though, to count out tech's heavyweights.

The Magnificent Seven stocks have returned 876% over the past 10 years. In comparison, the S&P 500 has only returned 235% over that same stretch.

Market sentiment appears overly defensive in certain areas, suggesting potential mispricing in risk assets. The analysis highlights top-tier BDCs, focusing on dividend yields, price/NAV, leverage, and credit quality. Main Street Capital (MAIN), Capital Southwest (CSWC), and Ares Capital (ARCC) offer strong yields with varying risk profiles.

I downgrade Roundhill Magnificent Seven ETF from buy to hold and do not recommend Roundhill Magnificent Seven Covered Call ETF. Heavy AI-driven CapEx among the Magnificent Seven is eroding free cash flow, shifting these companies from asset-light to asset-heavy models. MAGS trades at 28x earnings, still too high for a buy; I would reconsider if the multiple drops to 22x earnings.

The Magnificent Seven stocks, tracked by the MAGS ETF, have experienced valuation compression and technical weakness, now testing crucial support near $60. SA Quant has downgraded all Mag 7 stocks to Hold, citing high valuations despite strong profitability, with some scoring poorly on growth metrics as well.

Funds investing in high -yielding stocks like Exxon Mobil, Ford, Coca-Cola and Walmart are blowing it out of the water.

Magnificent 7 earnings are heating up as Apple, Microsoft, Meta and Tesla report, putting AI strategy, valuations and Mag-7 ETFs in the spotlight.

The Magnificent Seven have been running out of fuel well before we rang in the new year.

The "Magnificent Seven" stocks have all generated gains of at least 540% over the past decade. Their high valuations, however, have given investors some cause for concern.